Browse > Article
http://dx.doi.org/10.4070/kcj.2015.45.5.364

Elevation of the Serum Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 in Coronary Artery Disease  

Jin, Seon-Ah (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Seo, Hee Jung (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Kim, Sun Kyeong (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Lee, Yu Ran (Department of Physiology, Chungnam National University Hospital, Chungnam National University School of Medicine)
Choi, Sunga (Department of Physiology, Chungnam National University Hospital, Chungnam National University School of Medicine)
Ahn, Kye-Taek (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Kim, Jun-Hyung (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Park, Jae-Hyeong (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Lee, Jae-Hwan (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Choi, Si Wan (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Seong, In-Whan (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Jeon, Byeong Hwa (Department of Physiology, Chungnam National University Hospital, Chungnam National University School of Medicine)
Jeong, Jin-Ok (Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine)
Publication Information
Korean Circulation Journal / v.45, no.5, 2015 , pp. 364-371 More about this Journal
Abstract
Background and Objectives: Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) is a multifunctional protein involved in the DNA base excision repair pathway, inflammation, angiogenesis, and survival pathways. We investigated serum APE1/Ref-1 in patients with coronary artery disease (CAD). Subjects and Methods: Serum APE1/Ref-1 was measured with a sandwich enzyme-linked immunosorbent assay from 360 patients who received coronary angiograms. They were divided into two groups; a control (n=57) and a CAD group (n=303), the latter included angina (n=128) and myocardial infarction (MI, n=175). Results: The levels of APE1/Ref-1 were higher in the CAD than the control ($0.63{\pm}0.07$ vs. $0.12{\pm}0.07ng/100{\mu}L$, respectively; p<0.01). They were also higher in MI than angina ($0.81{\pm}0.10$ vs. $0.38{\pm}0.11ng/100{\mu}L$ L, respectively; p<0.01) and different according to the thrombolysis in myocardial infarction (TIMI) flow ($0.88{\pm}0.09$ for TIMI flow 0, 1, 2 vs. $0.45{\pm}0.13ng/100{\mu}L$ for TIMI flow 3, p<0.01) in acute coronary syndrome. In correlation analysis, the levels of APE1/Ref-1 were positively correlated with Troponin I (r=0.222; p<0.0001) and N-terminal pro-B type natriuretic peptide (NT-proBNP, r=0.217; p<0.0001) but not high sensitivity to C-reactive protein. Also, they revealed a negative correlation with ejection fraction (EF, r=-0.221; p=0.002). However, there were no significant differences among the three groups, were divided by their levels of APE1/Ref-1, for major adverse cardiovascular events (death, recurrent MI, stroke, revascularization) (8.2 vs. 14.0 vs. 12.5%, p=ns). Conclusion: The levels of serum APE1/Ref-1 are elevated in CAD, and are higher in MI than in angina. They are correlated with Troponin I, NT-proBNP, and EF.
Keywords
APEX1 protein, human; Ref-1 protein, human; Biological markers; Coronary artery disease;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Kim HC. Clinical utility of novel biomarkers in the prediction of coronary heart disease. Korean Circ J 2012;42:223-8.   DOI
2 Vasko MR, Guo C, Kelley MR. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA Repair (Amst) 2005;4:367-79.   DOI
3 Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004;3:679-86.   DOI
4 Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006;113:2335-62.   DOI
5 Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009;11:601-20.   DOI
6 Thakur S, Sarkar B, Cholia RP, Gautam N, Dhiman M, Mantha AK. APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions. Exp Mol Med 2014;46:e106.   DOI
7 Naganuma T, Nakayama T, Sato N, et al. Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension. Am J Hypertens 2010;23:186-91.   DOI
8 Zhang Y, Wang J Xiang D, Wang D, Xin X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int J Oncol 2009;35:1069-79.
9 Botto N, Rizza A, Colombo MG, et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 2001;493:23-30.   DOI
10 Mahmoudi M, Mercer J, Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc Res 2006;71:259-68.   DOI
11 Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;106:927-32.   DOI
12 Jeon BH, Gupta G, Park YC, et al. Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res 2004;95:902-10.   DOI
13 Choi S, Lee YR, Park MS, et al. Histone deacetylases inhibitor trichostatin A modulates the extracellular release of APE1/Ref-1. Biochem Biophys Res Commun 2013;435:403-7.   DOI
14 Patterson C. Blood pressure control goes nuclear. Circ Res 2004;95:849-51.   DOI
15 Song SH, Cho EJ, Park MS, et al. Redox regulating protein APE1/Ref-1 expression is increased in abdominal aortic coarctation-induced hypertension rats. J Korean Soc Hypertens 2012;18:126-35.   DOI
16 Park MS, Lee YR, Choi S, et al. Identification of plasma APE1/Ref-1 in lipopolysaccharide-induced endotoxemic rats: implication of serological biomarker for an endotoxemia. Biochem Biophys Res Commun 2013;435:621-6.   DOI
17 Dai N, Cao XJ, Li MX, et al. Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer. PLoS One 2013;8:e58001.   DOI
18 Shin JH, Choi S, Lee YR, et al. APE1/Ref-1 as a serological biomarker for the detection of bladder cancer. Cancer Res Treat 2015 Jan 2 [Epub]. http://dx.doi.org/10.4143/crt.2014.074.   DOI
19 Tell G, Damante G, Caldwell D, Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 2005;7:367-84.   DOI
20 Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000;461:83-108.   DOI
21 Pines A, Perrone L, Bivi N, et al. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 2005;33:4379-94.   DOI